300146 汤臣倍健
已收盘 01-13 15:00:00
资讯
新帖
简况
股市必读：汤臣倍健（300146）1月12日董秘有最新回复
证券之星 · 01:44
股市必读：汤臣倍健（300146）1月12日董秘有最新回复
股市必读：汤臣倍健（300146）1月7日董秘有最新回复
证券之星 · 01-08
股市必读：汤臣倍健（300146）1月7日董秘有最新回复
股市必读：汤臣倍健（300146）12月23日董秘有最新回复
证券之星 · 2025-12-24
股市必读：汤臣倍健（300146）12月23日董秘有最新回复
汤臣倍健：公司无应收账款质押情形
证券之星 · 2025-12-23
汤臣倍健：公司无应收账款质押情形
汤臣倍健：坚持差异化战略打造产品科技力
证券之星 · 2025-12-18
汤臣倍健：坚持差异化战略打造产品科技力
【机构调研记录】长盛基金调研汤臣倍健、博苑股份
证券之星 · 2025-12-10
【机构调研记录】长盛基金调研汤臣倍健、博苑股份
汤臣倍健：第四季度业绩受销售活动安排影响
证券之星 · 2025-12-09
汤臣倍健：第四季度业绩受销售活动安排影响
11月27日汤臣倍健发生1笔大宗交易 成交金额230.14万元
证券之星 · 2025-11-27
11月27日汤臣倍健发生1笔大宗交易 成交金额230.14万元
股市必读：汤臣倍健（300146）11月18日披露最新机构调研信息
证券之星 · 2025-11-20
股市必读：汤臣倍健（300146）11月18日披露最新机构调研信息
汤臣倍健：有知名机构正圆投资参与的多家机构于11月18日调研我司
证券之星 · 2025-11-19
汤臣倍健：有知名机构正圆投资参与的多家机构于11月18日调研我司
股市必读：汤臣倍健（300146）11月14日董秘有最新回复
证券之星 · 2025-11-17
股市必读：汤臣倍健（300146）11月14日董秘有最新回复
中原证券：运动营养市场为“基数小、增速快”的蓝海 关注汤臣倍健(300146.SZ)等基本面变化
智通财经 · 2025-11-14
中原证券：运动营养市场为“基数小、增速快”的蓝海 关注汤臣倍健(300146.SZ)等基本面变化
股市必读：汤臣倍健（300146）11月13日董秘有最新回复
证券之星 · 2025-11-14
股市必读：汤臣倍健（300146）11月13日董秘有最新回复
汤臣倍健：膳食营养补充剂行业发展将受益于国民健康意识提升
证券之星 · 2025-11-13
汤臣倍健：膳食营养补充剂行业发展将受益于国民健康意识提升
汤臣倍健副总陈宏为公司创始人之一 去年薪酬305.3万元 比总经理还高
运营商财经网 · 2025-11-09
汤臣倍健副总陈宏为公司创始人之一 去年薪酬305.3万元 比总经理还高
汤臣倍健：天风证券、中金公司等多家机构于10月31日调研我司
证券之星 · 2025-11-03
汤臣倍健：天风证券、中金公司等多家机构于10月31日调研我司
股市必读：汤臣倍健（300146）10月30日披露最新机构调研信息
证券之星 · 2025-10-31
股市必读：汤臣倍健（300146）10月30日披露最新机构调研信息
汤臣倍健(300146)9月30日股东户数7.11万户，较上期减少0.14%
证券之星 · 2025-10-29
汤臣倍健(300146)9月30日股东户数7.11万户，较上期减少0.14%
汤臣倍健最新公告：第三季度净利润1.71亿元同比扭亏
中金财经 · 2025-10-29
汤臣倍健最新公告：第三季度净利润1.71亿元同比扭亏
股市必读：汤臣倍健（300146）10月23日董秘有最新回复
证券之星 · 2025-10-24
股市必读：汤臣倍健（300146）10月23日董秘有最新回复
加载更多
公司概况
公司名称：
汤臣倍健股份有限公司
所属行业：
食品制造业
上市日期：
2010-12-15
主营业务：
汤臣倍健股份有限公司的主营业务是膳食营养补充剂的生产销售。公司的主要产品是片剂、粉剂、胶囊、其他。截至报告期末，公司获得134项原料及配方等发明专利。
发行价格：
110.00
{"stockData":{"symbol":"300146","market":"SZ","secType":"STK","nameCN":"汤臣倍健","latestPrice":12.44,"timestamp":1768287810000,"preClose":12.48,"halted":0,"volume":23941178,"delay":0,"changeRate":-0.0032,"floatShares":1121000000,"shares":1692000000,"eps":0.4088,"marketStatus":"已收盘","change":-0.04,"latestTime":"01-13 15:00:00","open":12.53,"high":12.67,"low":12.4,"amount":300000000,"amplitude":0.0216,"askPrice":12.44,"askSize":418,"bidPrice":12.43,"bidSize":105,"shortable":0,"etf":0,"ttmEps":0.4088,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768354200000},"marketStatusCode":5,"adr":0,"adjPreClose":12.48,"symbolType":"stock","openAndCloseTimeList":[[1768267800000,1768275000000],[1768280400000,1768287600000]],"highLimit":13.73,"lowLimit":11.23,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1691677031,"isCdr":false,"pbRate":1.87,"roa":"--","peRate":30.430528,"roe":"8.12%","epsLYR":0.39,"committee":0.412826,"marketValue":21044000000,"turnoverRate":0.0214,"status":1,"floatMarketCap":13943000000},"requestUrl":"/m/hq/s/300146","defaultTab":"news","newsList":[{"id":"2603540355","title":"股市必读：汤臣倍健（300146）1月12日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2603540355","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603540355?lang=zh_cn&edition=full","pubTime":"2026-01-13 01:44","pubTimestamp":1768239852,"startTime":"0","endTime":"0","summary":"截至2026年1月12日收盘，汤臣倍健报收于12.48元，上涨1.63%，换手率2.06%，成交量23.1万手，成交额2.87亿元。董秘最新回复投资者： 董秘您好，上海凡迪基因科技有限公司是一家专注于基因检测服务的高新技术企业，其核心业务聚焦于临床和健康领域的基因检测，与贵公司有着紧密的合作关系。公司已于2022年将上述股权全部处置，目前未持有上海凡迪股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300001452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","BK0114","BK0146","BK0226","BK0042","BK0028","300146"],"gpt_icon":0},{"id":"2601480054","title":"股市必读：汤臣倍健（300146）1月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2601480054","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601480054?lang=zh_cn&edition=full","pubTime":"2026-01-08 01:04","pubTimestamp":1767805453,"startTime":"0","endTime":"0","summary":"截至2026年1月7日收盘，汤臣倍健报收于12.15元，下跌1.7%，换手率1.46%，成交量16.32万手，成交额2.0亿元。董秘最新回复投资者： 您好！贵司CEO林志成在央视微对话中说将很快落地能从源头靶向清除衰老细胞的抗衰新物质PCC1的产品，能给更多相关产品的介绍吗？现在落地进度到哪一步了？具体请以公司正式发布的产品上市信息为准。交易信息汇总资金流向1月7日主力资金净流出2594.09万元；游资资金净流入2102.07万元；散户资金净流入492.02万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800000582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","300146","BK0226","BK0146","BK0114","BK0042","BK0028"],"gpt_icon":0},{"id":"2593141732","title":"股市必读：汤臣倍健（300146）12月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2593141732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593141732?lang=zh_cn&edition=full","pubTime":"2025-12-24 02:33","pubTimestamp":1766514790,"startTime":"0","endTime":"0","summary":"截至2025年12月23日收盘，汤臣倍健报收于12.02元，下跌1.15%，换手率1.16%，成交量12.98万手，成交额1.57亿元。董秘最新回复投资者： 尊敬的董秘，您好！2024年年报，短期借款激增至15.43亿元，年报显示是“已贴现未到期商业汇票”，请问这是质押的应收账款吗？上述主要系公司基于整体资金安排进行票据贴现业务所致，公司无应收账款质押情形。当日关注点来自交易信息汇总：12月23日主力资金净流出1099.32万元，散户资金净流入1564.95万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400001023.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0114","BK0107","BK0146","BK0226","BK0028","BK0042","300146"],"gpt_icon":0},{"id":"2593462320","title":"汤臣倍健：公司无应收账款质押情形","url":"https://stock-news.laohu8.com/highlight/detail?id=2593462320","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593462320?lang=zh_cn&edition=full","pubTime":"2025-12-23 15:06","pubTimestamp":1766473579,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)12月23日在投资者关系平台上答复投资者关心的问题。投资者提问：尊敬的董秘，您好！2024年年报，短期借款激增至15.43亿元，年报显示是“已贴现未到期商业汇票”，请问这是质押的应收账款吗？如果是，为什么“应收账款”科目仅有1.65亿？是遗漏了吗？激增这么多借款的原因是什么？谢谢！汤臣倍健回复：投资者您好！上述主要系公司基于整体资金安排进行票据贴现业务所致，公司无应收账款质押情形。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300018874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0107","300146","BK0114","BK0146","BK0226","BK0042"],"gpt_icon":0},{"id":"2592920997","title":"汤臣倍健：坚持差异化战略打造产品科技力","url":"https://stock-news.laohu8.com/highlight/detail?id=2592920997","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592920997?lang=zh_cn&edition=full","pubTime":"2025-12-18 15:06","pubTimestamp":1766041587,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健12月18日在投资者关系平台上答复投资者关心的问题。差异化是用户需求而其它企业没能满足的东西，而非仅仅是与众不同。没有差异化产品的商业模式基本不是好的商业模式。公司坚持执行差异化战略，在全球范围内科学甄选优质原料，深入开展自有知识产权原料、新功能和重功能创新产品开发，持续打造产品科技力和差异化竞争优势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800017388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK0028","BK0107","300146","BK0226","BK0042","BK0114"],"gpt_icon":0},{"id":"2590037861","title":"【机构调研记录】长盛基金调研汤臣倍健、博苑股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2590037861","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590037861?lang=zh_cn&edition=full","pubTime":"2025-12-10 08:05","pubTimestamp":1765325146,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及12月9日披露的机构调研信息，长盛基金近期对2家上市公司进行了调研，相关名单如下：1）汤臣倍健 调研纪要：公司聚焦主业，推动长期有质量发展。第四季度净利润受费用投放、奖金计提等影响。2）博苑股份 调研纪要：公司精细化学品主要包括碘化物、发光材料、六甲基二硅氮烷和贵金属催化剂，其中碘化物为营收核心。2025年12月11日将解除限售19,630,000股，目前未收到股东减持计划通知。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000004481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0028","BK0114","301617","BK0146","BK0042","BK0107","BK0226","BK0229"],"gpt_icon":0},{"id":"2590121143","title":"汤臣倍健：第四季度业绩受销售活动安排影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2590121143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590121143?lang=zh_cn&edition=full","pubTime":"2025-12-09 18:12","pubTimestamp":1765275130,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健12月09日在投资者关系平台上答复投资者关心的问题。另外，为什么过去几年，每年公司Q4都会出现业绩下滑？谢谢汤臣倍健回复：投资者您好！公司坚持规范信息披露，严格遵守法律法规的有关规定管理未公开信息，不存在内幕信息泄露或违反公平信披原则等违规情形。公司第四季度业绩受销售活动安排、市场费用投放节奏、奖金计提和费用结算等因素影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120900029030.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0107","BK0146","BK0114","BK0226","BK0042","300146"],"gpt_icon":0},{"id":"2586246182","title":"11月27日汤臣倍健发生1笔大宗交易 成交金额230.14万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586246182","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586246182?lang=zh_cn&edition=full","pubTime":"2025-11-27 17:41","pubTimestamp":1764236517,"startTime":"0","endTime":"0","summary":"证券之星消息，11月27日汤臣倍健发生大宗交易，交易数据如下：大宗交易成交价格12.44元，相对当日收盘价溢价1.8%，成交18.5万股，成交金额230.14万元，买方营业部为光大证券股份有限公司宁波柳汀街证券营业部，卖方营业部为光大证券股份有限公司宁波柳汀街证券营业部。近三个月该股共发生2笔大宗交易，合计成交3709.0手，折价成交1笔，溢价成交1笔。截至2025年11月27日收盘，汤臣倍健报收于12.22元，下跌0.65%，换手率1.03%，成交量11.52万手，成交额1.42亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700025876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0028","BK0114","BK0146","BK0042","BK0107","BK0226"],"gpt_icon":0},{"id":"2584921736","title":"股市必读：汤臣倍健（300146）11月18日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2584921736","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584921736?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:04","pubTimestamp":1763571858,"startTime":"0","endTime":"0","summary":"截至2025年11月18日收盘，汤臣倍健报收于12.7元，上涨0.79%，换手率2.25%，成交量25.27万手，成交额3.2亿元。当日关注点来自交易信息汇总：11月18日主力资金净流出1165.23万元，散户资金净流入394.8万元。来自机构调研要点：主品牌“汤臣倍健”定位全系列覆盖全人群，“健力多”与“lifespace”营收占比均已超10%。行业增量来自渗透率提升与新增人群扩容，VDS行业仍具增长空间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112000000453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0107","BK0146","BK0226","BK0042","BK0114","BK0028"],"gpt_icon":0},{"id":"2584995365","title":"汤臣倍健：有知名机构正圆投资参与的多家机构于11月18日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2584995365","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584995365?lang=zh_cn&edition=full","pubTime":"2025-11-19 10:02","pubTimestamp":1763517749,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年11月18日汤臣倍健发布公告称国盛证券陈熠、东吴证券邓洁、财通证券张立、易方达基金易俊何、中科沃土基金彭上、建信养老官忠涛、长江自营高辰星、广发自营高峰、正圆投资冯荃晴于2025年11月18日调研我司。汤臣倍健主营业务：膳食营养补充剂的研发、生产和销售。该股最近90天内共有7家机构给出评级，买入评级2家，增持评级4家，中性评级1家；过去90天内机构目标均价为14.25。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900008869.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0028","BK0107","BK0226","BK0146","BK0114","300146"],"gpt_icon":0},{"id":"2584660270","title":"股市必读：汤臣倍健（300146）11月14日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2584660270","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584660270?lang=zh_cn&edition=full","pubTime":"2025-11-17 01:17","pubTimestamp":1763313430,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，汤臣倍健报收于12.72元，下跌2.53%，换手率2.37%，成交量26.54万手，成交额3.42亿元。董秘最新回复投资者： 给公司提个建议：买了你们家儿童增高产品，但小朋友经常忘记按时吃，大人也不可能老提醒，所以，建议针对小朋友的营养健康产品，最好能配搭提供一个“提醒功能”的小电子玩具。每天提醒小朋友自觉服用。交易信息汇总资金流向11月14日主力资金净流出3219.86万元；游资资金净流入1697.62万元；散户资金净流入1522.25万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111700000469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0028","BK0114","BK0226","BK0042","BK0107","BK0146"],"gpt_icon":0},{"id":"2583081540","title":"中原证券：运动营养市场为“基数小、增速快”的蓝海 关注汤臣倍健(300146.SZ)等基本面变化","url":"https://stock-news.laohu8.com/highlight/detail?id=2583081540","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583081540?lang=zh_cn&edition=full","pubTime":"2025-11-14 11:20","pubTimestamp":1763090429,"startTime":"0","endTime":"0","summary":"整体看，运动营养市场呈现“基数小、增速快”的蓝海特征。A股上市公司中涉足运动营养的上市公司主要包括康比特、汤臣倍健和西王食品，建议关注这些上市公司的基本面变化。中国运动营养市场的增长远快于全球水平：2024年中国运动营养食品市场规模为97.1亿元，预计2030年增至209.3亿元，年均增长11.56%。与国际市场不同，在中国运动营养的市场集中度较高根据核算，截至2024年中国运动营养市场CR3达到70%，头部企业包括西王食品、康比特和汤臣倍健等。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369190.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0201","BK0107","BK0226","BK0276","BK0042","300146","BK0114","601375","BK0146","BK0028"],"gpt_icon":0},{"id":"2583165925","title":"股市必读：汤臣倍健（300146）11月13日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2583165925","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583165925?lang=zh_cn&edition=full","pubTime":"2025-11-14 03:32","pubTimestamp":1763062335,"startTime":"0","endTime":"0","summary":"截至2025年11月13日收盘，汤臣倍健报收于13.05元，上涨1.08%，换手率2.26%，成交量25.31万手，成交额3.27亿元。膳食营养补充剂行业发展将受益于国民健康意识提升、人口老龄化趋势加深及新生代消费群体扩容等。当日关注点来自交易信息汇总：11月13日主力资金净流入565.84万元，显示主力对个股呈积极介入态势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111400003148.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0226","BK0042","BK0114","BK0028","BK0107","BK0146"],"gpt_icon":0},{"id":"2583553941","title":"汤臣倍健：膳食营养补充剂行业发展将受益于国民健康意识提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2583553941","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583553941?lang=zh_cn&edition=full","pubTime":"2025-11-13 11:34","pubTimestamp":1763004845,"startTime":"0","endTime":"0","summary":"证券之星消息，汤臣倍健(300146)11月13日在投资者关系平台上答复投资者关心的问题。投资者提问：随着智能体、机器人的发展，机器代替人是大趋势，我国劳动就业率会长期不足，老百姓收入减少，相应的可选保健品购买也会减少。请问，公司如何应对这一宏观趋势？汤臣倍健回复：投资者您好！膳食营养补充剂行业发展将受益于国民健康意识提升、人口老龄化趋势加深及新生代消费群体扩容等。公司将持续关注经济环境与市场需求变化，适时调整经营策略。感谢关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300016788.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0226","300146","BK0146","BK0042","BK0107","BK0028","BK0114"],"gpt_icon":0},{"id":"2582899900","title":"汤臣倍健副总陈宏为公司创始人之一 去年薪酬305.3万元 比总经理还高","url":"https://stock-news.laohu8.com/highlight/detail?id=2582899900","media":"运营商财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582899900?lang=zh_cn&edition=full","pubTime":"2025-11-09 16:59","pubTimestamp":1762678740,"startTime":"0","endTime":"0","summary":"可以看出，陈宏为汤臣倍健初始创业人员之一，是元老级员工，已在公司副总经理职位上工作近20年。陈宏2024年薪酬为305.3万元，相较于2023年的500.0万元，下降了194.7万元，但仍高于总经理林志成，后者去年薪酬为230.7万元。汤臣倍健三季度财报显示，公司前三季度营业收入为49.15亿元，同比下降14.27%，归母净利润为9.07亿元，同比增长4.45%，呈现增利不增收的情形。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-11-09/doc-infwuxct2463004.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0114","BK0028","BK0146","BK0107","BK0226","300146","BK0042"],"gpt_icon":0},{"id":"2580259665","title":"汤臣倍健：天风证券、中金公司等多家机构于10月31日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2580259665","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580259665?lang=zh_cn&edition=full","pubTime":"2025-11-03 10:31","pubTimestamp":1762137074,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年10月31日汤臣倍健发布公告称天风证券陈潇 马咏怡 吴艾锜、中金公司王文丹、交银施罗德基金傅爱兵、博时基金钟天皓、长城基金覃晓露 申忆扬于2025年10月31日调研我司。汤臣倍健主营业务：膳食营养补充剂的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300007445.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0146","BK1564","BK0028","03908","BK0276","601995","BK0107","LU0359202008.SGD","LU1023057109.AUD","LU0359201885.HKD","LU1781817850.SGD","LU1580142542.USD","BK0114","BK0042","601162","BK1516","BK0226","SG9999002828.SGD","300146","BK1501","BK1147","LU0359201612.USD"],"gpt_icon":0},{"id":"2579789481","title":"股市必读：汤臣倍健（300146）10月30日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2579789481","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579789481?lang=zh_cn&edition=full","pubTime":"2025-10-31 01:42","pubTimestamp":1761846133,"startTime":"0","endTime":"0","summary":"截至2025年10月30日收盘，汤臣倍健报收于12.71元，上涨2.25%，换手率6.43%，成交量72.07万手，成交额9.33亿元。当日关注点来自交易信息汇总：10月30日主力资金净流出6399.68万元，散户资金净流入9216.02万元。来自机构调研要点：公司计划在2026年以“再创业”心态全线出击，聚焦产品创新与全球市场拓展。公司持续关注商誉是否存在减值迹象，并在每年度末聘请专业评估机构进行减值测试，具体请以公司定期报告为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100002477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","300146","BK0028","BK0114","BK0042","BK0146","BK0226"],"gpt_icon":0},{"id":"2579786789","title":"汤臣倍健(300146)9月30日股东户数7.11万户，较上期减少0.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579786789","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579786789?lang=zh_cn&edition=full","pubTime":"2025-10-29 17:33","pubTimestamp":1761730409,"startTime":"0","endTime":"0","summary":"证券之星消息，近日汤臣倍健披露，截至2025年9月30日公司股东户数为7.11万户，较6月30日减少100.0户，减幅为0.14%。在食品加工行业个股中，汤臣倍健股东户数高于行业平均水平，截至9月30日，食品加工行业平均股东户数为3.52万户。从股价来看，2025年6月30日至2025年9月30日，汤臣倍健区间涨幅为2.58%，在此期间股东户数减少100.0户，减幅为0.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900036373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0107","BK0226","BK0114","BK0042","BK0028","BK0146","300146"],"gpt_icon":0},{"id":"2579592094","title":"汤臣倍健最新公告：第三季度净利润1.71亿元同比扭亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2579592094","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579592094?lang=zh_cn&edition=full","pubTime":"2025-10-29 17:11","pubTimestamp":1761729079,"startTime":"0","endTime":"0","summary":"汤臣倍健(300146.SZ)发布2025年三季报，公司第三季度营业收入13.83亿元，同比增长23.45%；净利润1.71亿元，上年同期亏损2241.65万元。2025年前三季度营业收入49.15亿元，同比下降14.27%；净利润9.07亿元，同比增长4.45%；基本每股收益0.53元。第三季度，公司持续调整优化各渠道业务策略，单三季度收入和净利润同比均实现增长。为证券之星据公开信息整理，由AI算法生成(网信算备310104345710301240019号)，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251029/31747384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300146"],"gpt_icon":0},{"id":"2577158212","title":"股市必读：汤臣倍健（300146）10月23日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2577158212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577158212?lang=zh_cn&edition=full","pubTime":"2025-10-24 01:14","pubTimestamp":1761239649,"startTime":"0","endTime":"0","summary":"截至2025年10月23日收盘，汤臣倍健报收于12.06元，下跌0.41%，换手率1.37%，成交量15.32万手，成交额1.84亿元。董秘最新回复投资者： 请问轻络素审核是否已通过？公司已递交相关申报，目前尚在审批中。当日关注点来自交易信息汇总：10月23日主力资金净流出3045.98万元，显示主力短期减持动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102400001219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300146","BK0042","BK0146","BK0114","BK0107","BK0028","BK0226"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1768299323889,"stockEarnings":[{"period":"1week","weight":0.0188},{"period":"1month","weight":0.0722},{"period":"3month","weight":0.0676},{"period":"6month","weight":0.0796},{"period":"1year","weight":0.1532},{"period":"ytd","weight":0.0391}],"compareEarnings":[{"period":"1week","weight":0.0353},{"period":"1month","weight":0.0709},{"period":"3month","weight":0.0776},{"period":"6month","weight":0.1888},{"period":"1year","weight":0.3146},{"period":"ytd","weight":0.0495}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"汤臣倍健股份有限公司","boardCode":"AI0014","boardName":"食品制造业","stockholders":"71105人(较上一季度减少0.14%)","perCapita":"15762股","listingDate":"2010-12-15","address":"广东省珠海市金湾区三灶科技工业园星汉路19号","registeredCapital":"169167万元","survey":" 汤臣倍健股份有限公司的主营业务是膳食营养补充剂的生产销售。公司的主要产品是片剂、粉剂、胶囊、其他。截至报告期末，公司获得134项原料及配方等发明专利。","listedPrice":110},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"汤臣倍健(300146)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供汤臣倍健(300146)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"汤臣倍健,300146,汤臣倍健股票,汤臣倍健股票老虎,汤臣倍健股票老虎国际,汤臣倍健行情,汤臣倍健股票行情,汤臣倍健股价,汤臣倍健股市,汤臣倍健股票价格,汤臣倍健股票交易,汤臣倍健股票购买,汤臣倍健股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"汤臣倍健(300146)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供汤臣倍健(300146)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}